Manufacturers should focus on producing as many vaccines as possible this year, but the world faces a potential surplus next year in capacity, Moderna’s (MRNA.O) CEO said on Friday. Speaking at a virtual event on vaccine manufacturing, Stephane…
Moderna CEO says world faces 2022 COVID vaccine production surplus
